SCHEMBL2299722

SCHEMBL2299722

CCOC(=O)c1cc(-c2ccc(N)cc2C)no1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAOA P21397 1/20 0.48
HTT P42858 1/20 0.41
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 2/20 0.39
RAB9A P51151 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
ADORA3 P0DMS8 1/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 2/20 0.38
PRKCZ Q05513 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4D Q08499 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300298 0.89 LMNA (0.44) LMNACYP1A2CYP3A4MAOAHTT
SCHEMBL10147459 0.88 ALPL (0.44) LMNAHTTMAPTSMN1; SMN2GAA
SCHEMBL2294258 0.84 LMNA (0.54) LMNACYP1A2CYP3A4MAOAHTT
SCHEMBL6154640 0.84 KDM4E (0.42) CYP1A2MAPTGAAALDH1A1MEN1
SCHEMBL2296749 0.81 SMN1; SMN2 (0.55) LMNACYP1A2CYP3A4MAOAMAPT
SCHEMBL7669777 0.80 CYP1A2 (0.44) LMNACYP1A2CYP3A4MAOAHTT
SCHEMBL31124009 0.79 GAA (0.41) LMNACYP1A2HTTMAPTSMN1; SMN2
SCHEMBL2297766 0.78 KDM4E (0.43) LMNACYP1A2CYP3A4MAOAHTT
SCHEMBL29775670 0.78 MAPT (0.49) HTTMAPTRAB9AMEN1NPC1
SCHEMBL19814488 0.78 MAPT (0.49) HTTMAPTRAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835428-B2 Diacylglycerol acyltransferase inhibitors Piramal Enterprises Limited (IN) 2014-09-16 US disclosed
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED. 2011-08-11 US disclosed
WO-2010023609-A1 OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS DGAT1, DGAT2, DLAT LMNA 3819/4885CYP1A2 846/4885CYP3A4 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.